Biochemistry, Genetics and Molecular Biology
Trametinib
100%
Oncogene C Myc
100%
Upregulation
50%
Cell Proliferation
50%
Cell Death
50%
Chimera
50%
Protein Catabolism
50%
CRISPR
50%
Bone
50%
Messenger RNA
50%
Protein
50%
Protein Hydrolysis
50%
Interleukin-6
50%
Mouse Model
25%
Cell Growth
25%
Flow Cytometry
25%
MEK Inhibitor
25%
MAPK Signaling
25%
Cell Survival
25%
Cellular Differentiation
25%
Drug Resistance
25%
Luciferase
25%
Binocular Convergence
25%
NOD SCID Gamma Mouse
25%
Signal Transduction
25%
Growth
25%
Contrast
25%
Dynamics
25%
Real-Time Polymerase Chain Reaction
25%
Western Blot
25%
BRD4
25%
Medicine and Dentistry
Multiple Myeloma
100%
Myeloma
100%
Oncogene C Myc
100%
Bone Marrow Stromal Cell
40%
Trametinib
40%
Protein
20%
Messenger RNA
20%
In Vitro
20%
Programmed Cell Death
20%
Ex Vivo
20%
Upregulation
20%
Myeloma Cell
20%
Tumor Cell
20%
Cell Proliferation
20%
Protein Degradation
20%
Multiple Myeloma Cell Line
20%
Doxycycline
20%
Chimera
20%
Clustered Regularly Interspaced Short Palindromic Repeat
20%
Patient
20%
Cells
20%
Tumor Progression
10%
Combination Therapy
10%
Flow Cytometry
10%
MAPK Signaling
10%
MEK Inhibitor
10%
Signal Transduction
10%
Drug Resistance
10%
Cell Differentiation
10%
Xenograft
10%
Cell Survival
10%
Luciferase Assay
10%
Therapeutic Procedure
10%
Malignant Neoplasm
10%
Growth
10%
Cell Line
10%
Dependent Personality Disorder
10%
Immunology and Microbiology
Multiple Myeloma
100%
Oncogene C Myc
100%
Trametinib
40%
Tumor Cell
30%
Upregulation
20%
Myeloma Cell
20%
Cell Proliferation
20%
Cell Death
20%
Cells
20%
Protein Degradation
20%
Multiple Myeloma Cell Line
20%
Clustered Regularly Interspaced Short Palindromic Repeat
20%
Chimera
20%
Cell Survival
10%
Mouse Model
10%
Drug Resistance
10%
Bone Marrow Microenvironment
10%
Contrast
10%
Dynamics
10%
Cell Growth
10%
Growth
10%
Binocular Convergence
10%
MAPK Signaling
10%
Bone Marrow
10%
Signal Transduction
10%
Cell Differentiation
10%
Xenograft
10%
Flow
10%
NSG Mouse
10%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Myeloma
100%
Trametinib
33%
Protein
16%
Neoplasm
16%
Messenger RNA
16%
Doxycycline
16%
Cell Death
16%
Mouse Model
8%
Drug Resistance
8%
Mitogen Activated Protein Kinase Kinase Inhibitor
8%
Survival
8%
Malignant Neoplasm
8%
Tumor Growth
8%
Dependent Personality Disorder
8%
NOD SCID Gamma Mouse
8%
Cell Proliferation
8%
Flow Cytometry
8%
Luciferase
8%